Interestingly, Chen et al. showed that the accumulation of CCL21, the cognate ligand of CCR7, created an anti-tumor environment due to the increase of both the number of T cells and dendritic cells and the levels of IL-12 and IFN-γ at tumor site. This evidence concerns the gene IFNG and neoplasm.